Lord Udny-Lister (Con)

My Lords, in moving this amendment I will also speak to Amendments 148B to 148E and 149A. They follow a very similar theme to an earlier grouping that I spoke on. They seek to support the Government’s ambitions for a smoke-free generation, while ensuring that the legislation is both practical and proportionate. In passing legislation, we must ensure that we are responsive to science and inclusive of expertise and that transparency is not replaced by the opaqueness of ministerial discretion. This grouping therefore should be seen as a constructive route to getting the framework right, ensuring that regulation by the Bill is guided by science, informed by consultation and subject to practical and proper parliamentary oversight. Through Amendment 148A, I seek to make a very simple yet important improvement to the practical worth of Clause 96. I seek a requirement to be placed on the Secretary of State to publish an approved list of providers who are qualified to undertake the scientific studies that manufacturers are obliged to commission under this part of the Bill. If the Government are serious in their desire to safeguard consumers through this provision, this amendment would provide a mechanism to strengthen this aim, while further bringing transparency and fairness to the process. I further put it to the Committee that such a move would support smaller British firms that are developing lower-risk nicotine products, by giving them the confidence that the laboratories they engage with meet the Government’s regulatory standards. In pursuing this modest change to the Bill, we are following the established best practice of the global regulatory agencies, from the US FDA to the European Chemicals Agency, both of which maintain formal lists of approved testing bodies precisely to guarantee the integrity and compatibility of data. I therefore hope that this amendment would help streamline compliance and practically support smaller British businesses. With Amendments 148B and 148D I again seek to ensure that the Bill does not inadvertently drive adult smokers back to cigarettes. These amendments seek to reinforce the principle that regulation should correspond to risk and that we should encourage innovation in safer nicotine products, not penalise them. Through Amendment 148C, and as a theme that cross-references Amendments 148B and 148E, I ask the Government to accept consultation with manufacturers, retailers, scientists and adult consumers before regulations are made. If the Bill is to succeed in delivering what I believe are the Government’s intended outcomes, we must ensure that there is public trust by demonstrating that any regulations imposed are technically informed. I have tabled these amendments as I am keen to prevent poorly evidenced secondary legislation arising that might have unintended consequences. Tobacco control policy must be driven by scientific evidence, not ideology, and that is the basis of Amendment 148E. It would ensure that when future regulations are made about the composition or ingredients of nicotine products, they are assessed in a way that is relative to the harm caused by smoking. I put it to the Committee that comparative assessments are already standard across medicine, toxicology and food regulation and that the same principle ought to guide nicotine policy. Amendment 148E would encourage smarter, targeted regulation in a way that focuses efforts where harm is greatest. It would ensure that we continue to distinguish between products that kill and those that help people. Finally, in this grouping I have tabled Amendment 149A, as we need to ensure more adequate parliamentary oversight and accountability for the ministerial powers proposed in the Bill. One of my overriding concerns with the Bill is that its provisions are wide and, in many cases, open-ended. Through Amendment 149A I seek to preserve the constitutional norm that Parliament grants powers and departments exercise them. Through this amendment the Secretary of State would be required publish the rationale for any discretionary decisions. Beyond maintaining transparency in regulation, I believe that this is needed to protect both industry and consumers from uncertainty and ensure that there is fairness across the UK market. I beg to move.